Crossmark

Covalent-reversible peptide-based protease inhibitors. Design, synthesis, and clinical success stories

Crossref DOI link: https://doi.org/10.1007/s00726-023-03286-1

Published Online: 2023-06-17

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Feral, Anthony https://orcid.org/0000-0001-8896-9710
Martin, Anthony R. https://orcid.org/0000-0001-6187-6979
Desfoux, Alexandre https://orcid.org/0009-0006-7058-4197
Amblard, Muriel https://orcid.org/0000-0001-8922-1755
Vezenkov, Lubomir L. https://orcid.org/0000-0001-6348-7985
License Information

Text and Data Mining valid from 2023-06-17

Version of Record valid from 2023-06-17
More Information

Article History

Received: 30 March 2023

Accepted: 22 May 2023

First Online: 17 June 2023

Declarations

:

: The authors declare that they have no conflict of interest.